hexaminolevulinate (HAL)

DRUG2 trials

Sponsors

Photocure

Conditions

Cervical Intraepithelial NeoplasiaPharmacokinetics

Phase 1

An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers

CompletedNCT01050309

PhotocurePharmacokinetics

Start: 2009-11-30End: 2009-12-31Target: 8Updated: 2010-01-15

Phase 2

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

TerminatedNCT00708942

PhotocureCervical Intraepithelial Neoplasia

Start: 2009-01-31End: 2012-01-31Updated: 2013-04-24